1.Yueqi Li, Jingyi Li, Wenxing Li, Shuaiyi Liang, Wudi Wei, Jiemei Chu, Jingzhen Lai, Yao Lin, Hubin Chen, Jinming Su, Xiaopeng Hu, Gang Wang, Jun Meng, Junjun Jiang, Li Ye, Sanqi An, Scm6A: A Fast and Low-cost Method for Quantifying m6A Modifications at the Single-cell Level. Genomics, Proteomics & Bioinformatics. 2024. qzae039.

2. Bao Yi, Yaxin Chen, Lizhu Lin, Jingyi Li, Xinli Liu, Gang Wang, Yueqi Li, et al. 2024. “GutUDB: A Comprehensive Multiomics Database for Intestinal Diseases.” iMeta e195.

3. Chu J, Zheng R, Chen H, Chen Y, Lin Y, Li J, Wei W, Chen R, Deng P, Su J, Jiang J, Ye L, Liang H, An S. Dynamic m6 A profiles reveal the role of YTHDC2-TLR2 signaling axis in Talaromyces marneffei infection. J Med Virol. 2024 Feb;96(2):e29466.

4. Sanqi An#, Wanxu Huang#, Xiang Huang#, Yixian Cun, Weisheng Cheng, Xiang Sun, Zhijun Ren, Yaxin Chen, Wenfang Chen, and Jinkai Wang*. Integrative network analysis identifies cell-specifictrans regulators of m6A. Nucleic Acids Research, 48, 4: 1715-1729, 2020.

5. Yaxin Chen#, Gang Wang#, Jingyi Li, Lei Xia, Lin Zhu, Wenxing Li, Qiang Luo, Yinlu Liao, Yao Lin, Liyun Bi, Hubin Chen, Jiemei Chu, Yueqi Li, Jinming Su, Li Ye, Jun-Jun Jiang, Hao Liang*, Weimin Li*, Sanqi An*, CASA: a comprehensive database resource for the COVID-19 Alternative Splicing Atlas. J Transl Med. 2022 Oct 20;20(1):473.

6. Sanqi An#, Zhouhua Xie#, Yanyan Liao#, Junjun Jiang+, Wenyi Dong, Fuqiang Yin, Wen-Xing Li*, Li Ye*, Jianyan Lin*, Hao Liang*, Systematic analysis of clinical relevance and molecular characterization of m6A in COVID-19 patients, Genes & Diseases, 10.1016, 2022.

7. Sanqi An#, Yueqi Li#, Yao Lin#, Jiemei Chu, Jinming Su, Qiuli Chen, Hailong Wang, Peijiang Pan, Ruili Zheng, Jingyi Li, Junjun Jiang*, Li Ye*, Hao Liang*, Genome-Wide Profiling Reveals Alternative Polyadenylation of Innate Immune-Related mRNA in Patients With COVID-19, Frontiers in Immunology, 12:756288, 2021.

8. Sanqi An#, Ke He#, Fei Liu, Qianshan Ding, Yanli Wei, Zhenglin Xia, Xiaopeng Duan, Rui Huang, Bowei Li, Haihe Wang, Yu Tian, Guoan Xiang*, Wenxing Li*. Low microRNA150 expression is associated with activated carcinogenic pathways and a poor prognosis in patients with breast cancer. Oncology Reports, 45(3):1235-1248, 2021.

9. Xia Zhou#, Gonghua Li#, Sanqi An#, Wenxing Li, Huihui Yang, Yicheng Guo, Dai Zhi, Shaoxing Dai, Junjuan Zheng, Jingfei Huang*, Iavarone, A.*, Xudong Zhao*. A new method of identifying glioblastoma subtypes and creation of corresponding animal models. Oncogene, 37: 4781-4791, 2018.

10. Yixian Cun#, Sanqi An#, Haiqing Zheng#, Jing Lan, Wenfang Chen, Wanjun Luo, Chengguo Yao, Xincheng Li, Xiang Huang, Xiang Sun, Zehong Wu, Yameng Hu, Ziwen Li, Shuxia Zhang, Geyan Wu, Meisongzhu Yang, Miaoling Tang, Ruyuan Yu, Xinyi Liao, Guicheng Gao, Wei Zhao, Jinkai Wang*, Jun Li*, Specific Regulation of m6A by SRSF7 Promotes the Progression of Glioblastoma. Genomics, Proteomics & Bioinformatics, gpb.2021.11.001, 2021.

11. Renchao Zou#, Zhitian Shi#, Shufeng Xiao, Yang Ke, Tiangen Wu, Zhitang Guo, Fan Ni, Sanqi An*, and Lin Wang*. Co-expression analysis and ceRNA network reveal eight novel potential lncRNA biomarkers in hepatocellular carcinoma. Peer J, 2019.